Literature DB >> 12515290

Factor XIII and tissue transglutaminase antibodies in coeliac and inflammatory bowel disease.

Klas Sjöber1, Sten Eriksson, Birgitta Tenngart, E Bodil Roth, Hakon Leffler, Pål Stenberg.   

Abstract

Tissue transglutaminase (tTg) has been identified as an autoantigen in coeliac disease (CD). There is a marked homology between different forms of transglutaminase, such as tTg and coagulation factor XIII. We compared titres of both IgA- and IgG-antibodies against these two antigens in 20 CD patients, 20 endomysial antibody (EMA)-negative controls and a group with inflammatory bowel disease (34 with Crohn's disease and 23 with ulcerative colitis). IgA-antibodies against tTg correlated with EMA titres and had high sensitivity and specificity in screening for CD. Only in two CD patients were high titres found of IgA-antibodies against factor XIII, non-reactive with tTg. Both lacked bleeding tendency. The presence of IgG-antibodies against tTg, in contrast, had low sensitivity and specificity in screening for CD and were frequently seen in inflammatory bowel disease. Similarly, factor XIII IgG-antibodies displayed a non-specific pattern with modestly elevated titres in patients with Crohn's disease and in both EMA-negative and positive patients. Despite a marked homology with tTg, the occurrence of high titre IgA-antibodies against factor XIII is infrequent in CD, but may-when present-be the result of epitope spreading. The presence of IgG-antibodies in CD and inflammatory bowel disease illustrates the complexity of autoantibody reactions in gastrointestinal disease.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12515290     DOI: 10.1080/73-0891693021000005402

Source DB:  PubMed          Journal:  Autoimmunity        ISSN: 0891-6934            Impact factor:   2.815


  5 in total

1.  Long term diarrhoea caused by simultaneous Crohn's disease and coeliac disease in the same patient.

Authors:  Mehrnaz Asadi; Fateme Malekzadeh; Nader Roshan
Journal:  BMJ Case Rep       Date:  2010-03-17

2.  A single conformational transglutaminase 2 epitope contributed by three domains is critical for celiac antibody binding and effects.

Authors:  Zsófia Simon-Vecsei; Róbert Király; Péter Bagossi; Boglárka Tóth; Ingrid Dahlbom; Sergio Caja; Éva Csosz; Katri Lindfors; Daniele Sblattero; Éva Nemes; Markku Mäki; László Fésüs; Ilma R Korponay-Szabó
Journal:  Proc Natl Acad Sci U S A       Date:  2011-12-22       Impact factor: 11.205

3.  The polygenic nature of inhibitors in hemophilia A: results from the Hemophilia Inhibitor Genetics Study (HIGS) Combined Cohort.

Authors:  Jan Astermark; Sharyne M Donfield; Edward D Gomperts; John Schwarz; Erika D Menius; Anna Pavlova; Johannes Oldenburg; Bailey Kessing; Donna M DiMichele; Amy D Shapiro; Cheryl A Winkler; Erik Berntorp
Journal:  Blood       Date:  2012-12-06       Impact factor: 22.113

Review 4.  Coeliac disease and autoimmune disease-genetic overlap and screening.

Authors:  Knut E A Lundin; Cisca Wijmenga
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2015-08-25       Impact factor: 46.802

Review 5.  Celiac disease and autoimmune-associated conditions.

Authors:  Eugenia Lauret; Luis Rodrigo
Journal:  Biomed Res Int       Date:  2013-07-24       Impact factor: 3.411

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.